bromodeoxyuridine has been researched along with deferasirox in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
McTigue, DM; Schonberg, DL | 1 |
1 other study(ies) available for bromodeoxyuridine and deferasirox
Article | Year |
---|---|
Iron is essential for oligodendrocyte genesis following intraspinal macrophage activation.
Topics: Animals; Antigens; Benzoates; Bromodeoxyuridine; CD11b Antigen; Cell Proliferation; Deferasirox; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Ferritins; Gene Expression Regulation; Injections, Spinal; Intracellular Signaling Peptides and Proteins; Iron; Iron Chelating Agents; Lipopolysaccharides; Macrophage Activation; Macrophages; Oligodendroglia; Proteoglycans; Rats; Rats, Sprague-Dawley; Time Factors; Triazoles | 2009 |